]]>
The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026
In 2019, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2019.
Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multi-potent. The cells are majorly isolated from bone marrow, and umbilical cord blood.
The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years.
Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.
North America generated the highest revenue in the Regenerative Medicine market in 2019, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region.
While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.
The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard.
These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.
Key Topics Covered:
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Regenerative Medicine Market Insights
3.1. Regenerative Medicine - Industry snapshot
3.2. Regenerative Medicine - Ecosystem analysis
3.3. Regenerative Medicine Market Dynamics
3.3.1. Regenerative Medicine - Market Forces
3.3.1.1. Regenerative Medicine Market Driver Analysis
3.3.1.2. Regenerative Medicine Market Restraint/Challenges analysis
3.3.1.3. Regenerative Medicine Market Opportunity Analysis
3.4. Industry analysis - Porter's five force
3.5. Regenerative Medicine Market PEST Analysis
3.6. Regenerative Medicine Market Value Chain Analysis
3.7. Regenerative Medicine Industry Trends
3.8. Competitive Ranking Analysis
4. Regenerative Medicine Market Size and Forecast by Therapy Type, 2015-2026
4.1. Key Findings
4.2. Tissue engineering
4.3. Cell Therapy
4.4. Immunotherapy
4.5. Gene Therapy
5. Regenerative Medicine Market Size and Forecast by Product Type, 2015-2026
5.1. Key Findings
5.2. Acellular Products
5.3. Cellular Products
5.4. Autologous Products
5.5. Allogeneic Products
6. Regenerative Medicine Market Size and Forecast by Application Type, 2015-2026
6.1. Key Findings
6.2. Oncology
6.3. Dermatology
6.4. Orthopedic
6.5. Cardiology
6.6. CNS Disease
6.7. Diabetes
7. Regenerative Medicine Market Size and Forecast by Region, 2015-2026
8. Company Profiles]]>
]]>
The global rapid medical diagnostic kits market size is predicted to reach USD 23.04 billion by 2027
Rapid medical diagnostic kits are also known as 'immediate test kits' which are designed to provide instant access to diagnose the patients or the individual with several types of diseases. The rapid medical diagnostic kits can be accessed 24/7 and help to deliver the immediate course of action during an emergency period. The rapid medical diagnostic kits are also cost-effective and easy to access anywhere.
Recent developments in the global market include the new test launches such as SARS-CoV-2 rapid antigen test, 2019-nCoV IgG/IgM test kit, On-Call Sure Platform, Afinion HbA1c Dx, TruQuick, etc. The launches are associated with the diagnosis of diseases such as cardiac disorder, diabetes, infectious disease, and others, which further leads to drive the market growth.
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. For instance, in July 2020, Bupa UK Insurance announced to launch a rapid cardiac assessment service which can be accessible at home and can perform all the diagnostic tests.
Market participants include Zoetis, ACON Laboratories, Inc.; Trinity Biotech, Abbott Laboratories, McKesson Medical-Surgical, Inc.; Sight Diagnostics Ltd, F. Hoffmann-La Roche AG, Artron Laboratories Inc.; Meridian Bioscience, Inc.; Alfa Scientific Designs, Inc.; Creative Diagnostics, Becton, Danaher Corporation, Dickinson and Company, Bio-Rad Laboratories, Inc.; BTNX, Inc.; Cardinal Health, and bioMerieux SA among others.
For instance, in March 2020, Thermo Fisher Scientific has acquired a supplier of sample preparation and molecular diagnostics technologies to enhance the company's reach globally and therefore drive the market growth. This acquisition strategy by the market players has appeared to dominate a wide share of the global market.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Rapid Medical Diagnostic Kits Market Insights
4.1. Rapid Medical Diagnostic Kits - Industry snapshot
4.2. Rapid Medical Diagnostic Kits Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Emergence of COVID-19
4.2.1.2. Surge in infectious diseases
4.2.2. Restraints and Challenges
4.2.2.1. Dearth of experienced professionals
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Rapid Medical Diagnostic Kits Market Industry trends
5. Rapid Medical Diagnostic Kits Market Assessment by Product
5.1. Key Findings
5.2. Introduction
5.3. Professional
5.4. Over-The-Counter (OTC)
6. Rapid Medical Diagnostic Kits Market Assessment by Technology
6.1. Key Findings
6.2. Introduction
6.3. Agglutination
6.4. Solid Phase
6.5. Lateral Flow
6.6. Others
7. Rapid Medical Diagnostic Kits Market Assessment by Application
7.1. Key Findings
7.2. Introduction
7.3. Lipid Profile Testing
7.4. Blood Glucose Testing
7.5. Toxicology Testing
7.6. Infectious Disease Testing
7.7. Coagulation Testing
7.8. Cardiometabolic Testing
7.9. Fecal Occult Blood Testing
7.10. Pregnancy and Fertility Testing
8. Rapid Medical Diagnostic Kits Market Assessment by End-Use
8.1. Key Findings
8.2. Introduction
8.3. Home Care
8.4. Hospitals & Clinics
8.5. Diagnostic Laboratories
9. Rapid Medical Diagnostic Kits Market Assessment by Geography
9.1. Key findings
9.2. Introduction
9.2.1. Rapid Medical Diagnostic Kits Market Assessment, By Geography, 2016-2027 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Company Overview
11.2. Financial Performance
11.3. Product/Application Benchmarking
11.4. Recent Developments]]>
The global virtual clinical trials market size is expected to reach USD 13.78 billion by 2027
Virtual Clinical Trials (VCT) are a new method of directing clinical trials which is inclusive of web platforms (informed consent, recruitment, adverse reactions, counseling and measurement of endpoints) and taking advantage of technology such as monitoring devices, apps and others. VCT also allows participant to be home-based at all clinical trial stage. VCT are operationally feasible and have lower drop-out rates, higher recruitment rates, better compliance and are faster than traditional method.
The growth of virtual clinical trials is mainly owing to the advantages offered by these trials in place of traditional clinical trials. The cost of development of a new drug estimates more than a 2 billion dollars and approximately two-third of the total cost is consumed in clinical testing phase.
Moreover, delay in clinical trials is majorly caused by patient recruitment resulting in loss of revenue of millions of dollars per day for the pharmaceutical companies. Furthermore, participant drop out is another major challenges faced in the clinical testing. To overcome these challenges major healthcare and pharmaceutical companies and organizations are constantly aiming on adopting new technology by investing in virtual clinical trial solutions, which is expected to escalate the overall market on a global level.
The prominent factors favoring the global market growth include scarcity of time in traditional clinical trials, rising R&D for the development of new drugs and vaccines, adoption of telemedicine and increasing demand for patient diversity. Additionally, COVID-19 pandemic has led to upsurge virtual clinical trials given the trials need to be conducted digitally.
Thereby, companies all around the globe are aiming on developing virtual trial technologies to meet the growing demand for solutions to fight Covid-19. For instance, in June 2020, TRHC (Tabula Rasa HealthCare), developer of healthcare software solutions, announced its partnership with Regence BlueShield, a health plan provider, for conducting virtual trials for different drug candidates, and to examine the ADEs (adverse drug events) in each.
Market participants such as LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Oracle Corporation, Medable, Inc., Parexel International, Clinical Ink, Inc., PRA Health Sciences, Science 37 and ICON plc. are some of the key players operating in the global market.
Players in the market are strategizing on developing new virtual clinical trial technology to cope up with the augmenting healthcare industry and thereby, establish their market place.
For instance, in May 2020, AiCure LLC, an advanced data analytics and artificial intelligence company, partnered with Science 37, a clinical research company, to leverage a decentralized research model for enabling home based clinical trial for assessing an experimental drug for major depression disorder (MDD).
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Virtual Clinical Trials Market Insights
4.1. Virtual Clinical Trials - Industry snapshot
4.2. Virtual Clinical Trials Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Need for digitization in clinical trials
4.2.1.2. Fear among clinical investigators for COVID-19
4.2.2. Restraints and Challenges
4.2.2.1. High upfront costs
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Virtual Clinical Trials Market Industry trends
5. Virtual Clinical Trials Market Assessment by Design
5.1. Key Findings
5.2. Introduction
5.3. Observational Trials
5.4. Interventional Trials
5.5. Expanded Access Trials
6. Global Virtual Clinical Trials Market, by Indication
6.1. Key Findings
6.2. Introduction
6.3. CNS
6.4. Autoimmune/Inflammation
6.5. Cardiovascular Disease
6.6. Metabolic/Endocrinology
6.7. Infectious Disease
6.8. Oncology
6.9. Genitourinary
6.10. Ophthalmology
7. Global Virtual Clinical Trials Market, by Phases
7.1. Key Findings
7.2. Introduction
7.3. Phase I
7.4. Phase II
7.5. Phase III
7.6. Phase IV
8. Virtual Clinical Trials Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Virtual Clinical Trials Market Assessment, By Geography, 2016- 2027 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion Analysis
9.1.2. Acquisition Analysis
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Company Overview
10.2. Financial Performance
10.3. Product Benchmarking
10.4. Recent Developments]]>
The global Cannabidiol Oil (CBD Oil) Market size is expected to reach USD 24.08 billion by 2027
CBD is commonly used to relieve anxiety and it helps the insomnia patients in falling asleep and staying asleep. Certain CBD manufacturers have been scrutinized by the government who claim that CBD is a cure for cancer.
Research about the balance of pros and cons of CBD is ongoing near every production and consumption cluster, and debates about their usage is being carried out in all of the regions wherever there are significant number of potential prospective consumers. Overall CBD has a large addressable market, of which a large part is untouched.
Affirmation of the therapeutic value of cannabis by the WHO, and the U.S. National Academies of Sciences, helps challenging un-supportive views, and encourages governments, research scholars, health-care providers, and consumers to consider its potential. Medical community across the globe recognized its potential value and legalization, thereby burgeoning demand for the medical cannabis.
The Oxford University, one of the world's foremost research institutions, announced to launch a US$ 12.36 million medical cannabis research program. The research in the U.S. will still have difficulties over reaching to the upmost standard because of the continuous classification of Cannabis as a schedule 1 drug.
Though it allows institutes of foreign origin to initiate medical cannabis program and projects a scope of development to the markets where it is yet form its hold. Institutes follow a routine method in conducting research over the benefits and characteristic of CBD and marking the properties in use for medical conditions.
Demand for procedure in elderly population is affecting the socioeconomic environment surrounding medical care. Moreover, healthcare services for the elderly are government-subsidized. It is still not something clearly observed in every middle economy or developing country but effects a large number of population in response to provide aid.
Medical cannabis is not limited to certain conventional products such as oil spray, dried form, tinctures and tea, the main move is to create a consumer friendly approach in considering cannabis as a drug. Many facilities are open to rediscover it as a medicine in a more prosperous way by engaging consumers to social clubs.
Manufacturers are producing products that are better in use on the social platform with engaging product offerings for a better usage trend. The initiative of considering medical cannabis as a socially accepted medicine for pain relief and other problems is sourced in such social clubs also known as cannabis clubs.
Market participants such as Isodiol, Canopy Growth Corporation, Tilray, Medical Marijuana Inc., NuLeaf Naturals, CV Sciences, Aurora Cannabis, Green Roads, Folium Biosciences, GW Pharmaceuticals, Charlotte's Web, CW Hemp, Endoca, Medterra, Elixinol and Gaia Herbs, LLC. are some of the key players operating in the global market.
In June 2020, Perrigo Company plc, the U.S. based provider of self care products across the globe announced its entry in the Cannabidiol Oil Market through its strategic investment in Kazmira LLC, a Colorado based CBD products supplier. Perrigo acquired 20 per cent equity stake in Kazmira.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Cannabidiol Oil Market Insights
4.1. Cannabis Oil - Industry snapshot
4.2. Cannabidiol Oil Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Favorable legislation across the world
4.2.1.2. Increased usage in pharmaceutical industry
4.2.2. Restraints and Challenges
4.2.2.1. Abuse among younger generation
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Cannabidiol Oil Market Industry trends
5. Cannabidiol Oil Market Assessment by Source
5.1. Key Findings
5.2. Introduction
5.3. Hemp Derived
5.4. Marijuana Derived
6. Global Cannabidiol Oil Market, by Form
6.1. Key Findings
6.2. Introduction
6.3. Process Oil
6.4. Distillate
6.5. Isolate
7. Global Cannabidiol Oil Market, by Grade
7.1. Key Findings
7.2. Introduction
7.3. Food
7.4. Therapeutic
8. Cannabidiol Oil Market Assessment by Application
8.1. Key Findings
8.2. Introduction
8.3. Food and Beverages
8.4. Cosmetics and Personal Care
8.5. Pharmaceuticals
8.6. Others
9. Cannabidiol Oil Market Assessment by Geography
9.1. Key findings
9.2. Introduction
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisition
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles]]>
The next gen learning management system (LMS) market for higher education is poised to grow by $ 3.04 bn, progressing at a CAGR of 29% during the forecast period.
The market is driven by the need for cost-effective LMS for higher education and enhanced content management features.
The report on next gen learning management system (LMS) market for higher education provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The next gen learning management system (LMS) market for higher education analysis includes application segment and geographic landscape.
This study identifies inclusion of analytics in LMS as one of the prime reasons driving the next gen learning management system (LMS) market for higher education growth during the next few years.
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next gen learning management system (LMS) market for higher education vendors that include Blackboard Inc., D2L Corp., Docebo Inc., Edmodo, Growth Engineering, Instructure Inc., Jenzabar Inc., N2N Services Inc., PowerSchool Group LLC, and Saba Software Inc.
Also, the next gen learning management system (LMS) market for higher education analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers.
The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Key Topics Covered:
Executive Summary]]>
]]>
]]>